Health Condition 1: N179- Acute kidney failure, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with age > 18 years with acute kidney injury (AKI) stage 2 and 3 as defined by KDIGO or Acute on Chronic Kidney disease for whom SLED was prescribed by the treating physician 2. Serum Na less than 135 mmol/L OR more than 145 mmol/L will be screened to be included in the study. 3. Patients with dysnatremia who undergo one session of SLED will be included only once in the study
Exclusion criteria
Exclusion criteria: 1. The patients whose pre dialysis Na is between 135-145 mmol/L 2. The patients who could not complete the SLED session scheduled for 8-10 hours 3. Patients who were end stage renal disease and received dialysis before enrolment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 30 day all cause mortality after starting SLED in patients with dysnatremiaTimepoint: 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To correlate the change in Na (Pre-post) dialysis to 30 day mortality To correlate the severity of dysnatremia with 30 day mortality Factors associated with 30 day mortalityTimepoint: 30th day | — |
Countries
India
Contacts
King George Medical University